Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Therapeutics × Gynecologic × Clear all

Phase

Status

Sponsor Class

OTHER 19 NETWORK 2 INDUSTRY 2 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1 Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Cisplatin 6 apatinib 5 Surgical Procedures, Operative 4 Paclitaxel 4 Hydralazine 4 Gemcitabine 4 Carboplatin 4 Valproic Acid 3 Radiotherapy 3 Neoadjuvant Therapy 3 Hyperthermic Intraperitoneal Chemotherapy 3 Drug Therapy 3 Bevacizumab 3 taxane 2 pembrolizumab 2 cetrorelix 2 Radiotherapy, Intensity-Modulated 2 Probiotics 2 Poly(ADP-ribose) Polymerase Inhibitors 2 Metformin 2 Laparoscopy 2 Curcumin 2 CP protocol 2 spartalizumab 1 piperine 1 olaparib 1 niraparib 1 nimotuzumab 1 lenvatinib 1 fluzoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07181278 2025-12-02

OptiTri_MT

Institut de Recherche pour le Developpement

Phase NA Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡